CLOs on the Move

GreenwichBiosciences

www.greenwichbiosciences.com

 
Greenwich Biosciences is the leader in researching cannabinoid medicines for rare epilepsies like Dravet Syndrome, LGS, TSC, and others.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Jeff Lemay
Sr. Director, U.S. Compliance Officer Profile
Joshua Eizen
VP, General Counsel Profile
Dennis Ahern
Vice President, Global Regulatory Affairs Profile

Similar Companies

Pinnacle Pharmaceutics

Pinnacle Pharmaceutics Ltd is a Whitby, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Digestive Care Inc

Digestive Care Inc is a Bethlehem, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sagimet

Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways. The company has unique expertise in FASN biology and has created a platform of proprietary FASN inhibitors.

Bell Pharmaceuticals

Bell Pharmaceuticals is a Belle Plaine, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Baxter International

Baxter International Inc. is a Fortune 500 American health care company with headquarters in Deerfield, Illinois.